These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8597519)
21. Decreased binding sites of angiotensin II in rat LY-80 and AH109A tumour and human gastric cancer using quantitative in vitro autoradiography. Kohzuki M; Tanda S; Hori K; Suzuki M; Yoshida K; Sato T Int Angiol; 2000 Mar; 19(1):52-8. PubMed ID: 10853686 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Ruiz-Ortega M; Lorenzo O; Rupérez M; Suzuki Y; Egido J Nephrol Dial Transplant; 2001; 16 Suppl 1():27-33. PubMed ID: 11369817 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of decreased pressor responsiveness to ANG II, NE, and vasopressin in pregnant rats. Paller MS Am J Physiol; 1984 Jul; 247(1 Pt 2):H100-8. PubMed ID: 6377924 [TBL] [Abstract][Full Text] [Related]
24. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. Leung WT; Lau WY; Ho SK; Chan M; Leung NW; Lin J; Metreweli C; Johnson PJ; Li AK J Nucl Med; 1994 Jan; 35(1):70-3. PubMed ID: 8271063 [TBL] [Abstract][Full Text] [Related]
25. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. Ullian ME; Linas SL J Clin Invest; 1989 Sep; 84(3):840-6. PubMed ID: 2760215 [TBL] [Abstract][Full Text] [Related]
26. Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells. Burnier M; Centeno G; Waeber G; Centeno C; Bürki E Br J Pharmacol; 1995 Nov; 116(5):2524-30. PubMed ID: 8581294 [TBL] [Abstract][Full Text] [Related]
27. [Hepatic blood flow in patients treated by continuous hepatic artery infusion chemotherapy]. Nakamura K Kaku Igaku; 1992 Mar; 29(3):377-83. PubMed ID: 1316501 [TBL] [Abstract][Full Text] [Related]
28. Increased hepatic arterial blood flow after decreased portal supply to the liver parenchyma owing to intrahepatic portosystemic venous shunt: angiographic demonstration using helical CT. Yamagami T; Arai Y; Takeuchi Y; Nakamura T; Inaba Y; Matsueda K; Nishimura T Br J Radiol; 2000 Oct; 73(874):1042-5. PubMed ID: 11271895 [TBL] [Abstract][Full Text] [Related]
29. Assessment of tumor hemodynamics in small hepatocellular carcinoma: comparison of Doppler ultrasonography, angiography-assisted computed tomography, and pathological findings. Kumada T; Nakano S; Toyoda H; Hayashi K; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamamoto A; Takeshima K; Hibi T; Yabashi T; Noda T; Sassa T; Furukawa M; Ogawa S Liver Int; 2004 Oct; 24(5):425-31. PubMed ID: 15482338 [TBL] [Abstract][Full Text] [Related]
30. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors. Brännström K; Morsing P; Arendshorst WJ Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835 [TBL] [Abstract][Full Text] [Related]
31. Angiotensin alteration of drug uptake in an experimental model of hepatic metastases. Trezona T; Butler JA; Vargas H J Surg Res; 1991 Aug; 51(2):124-7. PubMed ID: 1830915 [TBL] [Abstract][Full Text] [Related]
32. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins. Hennenberg M; Trebicka J; Biecker E; Schepke M; Sauerbruch T; Heller J Hepatology; 2007 Feb; 45(2):495-506. PubMed ID: 17256744 [TBL] [Abstract][Full Text] [Related]
33. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes. Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854 [TBL] [Abstract][Full Text] [Related]
34. Oxygen-15 positron-emission tomography for predicting selective delivery of a chemotherapeutic agent to hepatic cancers during angiotensin II-induced hypertension. Koh T; Taniguchi H; Yamagishi H Cancer Chemother Pharmacol; 2003 Apr; 51(4):349-58. PubMed ID: 12721763 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838 [TBL] [Abstract][Full Text] [Related]
36. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats. Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of sodium modulation of glomerular angiotensin receptors in the rat. Bellucci A; Wilkes BM J Clin Invest; 1984 Nov; 74(5):1593-600. PubMed ID: 6094612 [TBL] [Abstract][Full Text] [Related]
38. Portal hemodynamics in patients with hepatocellular carcinoma. Moriyasu F; Ban N; Nishida O; Nakamura T; Soh Y; Miura K; Sakai M; Miyake T; Uchino H Radiology; 1986 Dec; 161(3):707-11. PubMed ID: 3024207 [TBL] [Abstract][Full Text] [Related]
39. Cyclosporine augments renal but not systemic vascular reactivity. Garr MD; Paller MS Am J Physiol; 1990 Jan; 258(1 Pt 2):F211-7. PubMed ID: 2301592 [TBL] [Abstract][Full Text] [Related]
40. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Ruan X; Arendshorst WJ Am J Physiol; 1996 Jun; 270(6 Pt 2):F945-52. PubMed ID: 8764313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]